The Australian Pesticides and Veterinary Medicines Authority (APVMA) has approved a novel injectable form of BRAVECTO QUANTUM.
It makes Australia the first country to gain approval for the novel injectable which is used for the control of paralysis tick (Ixodes holocyclus) for 12 months, the treatment and prevention of flea (Ctenocephalides felis) infestations for 12 months, the control of brown dog tick (Rhipicephalus sanguineus ) for 11 months, and the control of flea allergy dermatitis (FAD).
Eric Flanagan, General Manager of Australia and New Zealand at MSD Animal Health, said that MSD has always been committed to ensuring veterinarians are at the forefront of pet owner education and advice when it comes to their products.
“BRAVECTO QUANTUM is no exception; we are excited that Australia is the first country in the world to launch this game-changing treatment that can only be administered by or under supervision of veterinarians. We firmly believe veterinarians are best placed to explain the efficacy and compliance benefits of BRAVECTO QUANTUM to dog owners.”
Unique to Australia’s eastern seaboard is the paralysis tick, the single most dangerous parasite for dogs with just one tick capable of causing paralysis and even death, highlighting the importance of this announcement.
Dr Jason Drake, Director, Scientific Marketing Affairs, Global Companion Animal Parasiticides, at MSD Animal Health, said though we typically think of paralysis tick season occurring during the summer months, we know these deadly parasites can be a threat year-round.
“Similarly, fleas can strike at any time during the year. Missed doses of monthly treatments leave gaps in protection; with a once-yearly dosing, BRAVECTO QUANTUM provides a long duration of protection, simplifying paralysis tick and flea protection for both pet owners and veterinarians, which promotes compliance and ensures continuous year-long protection.”
The active ingredient in BRAVECTO QUANTUM is fluralaner, an isoxazoline that has been used by veterinarians to protect dogs from fleas and ticks since 2014. The unique crystallized fluralaner in suspension allows for sustained effective levels of active ingredient to be maintained as the fluralaner is gradually absorbed from the site of the injection, providing ongoing efficacy against fleas and paralysis ticks for 12 months and efficacy against brown dog ticks for 11 months.
To stay up to date on the latest industry headlines, sign up to the Pet Industry News e-newsletter.